{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:32:42Z","timestamp":1791066762884,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    HECT and RCC1-like domain-containing protein 1 (HERC1), a large E3 ubiquitin ligase, has been implicated in neural development and genome stability, but its role in cancer remains unclear. This study identifies HERC1 as a critical regulator of cancer stemness, metastasis, and chemoresistance in head and neck squamous cell carcinoma (HNSCC). CD44\u207a HNSCC organoids with shRNA-mediated HERC1 knockdown were assessed for stemness, EMT, and IL-6\/STAT3\/HERC1 signaling using molecular assays, CAF co-culture, xenografts, and tissue immunohistochemistry. High HERC1 expression in TCGA-HNSCC datasets was associated with enrichment of stemness signatures. HERC1 knockdown in CD44\u207a cells reduced Sox2, and Slug expression, suppressed EMT, and impaired metastatic potential in Transwell assays and in vivo models. CD44\u207a cells formed organoids in a HERC1-dependent manner. CAF co-culture showed that IL-6 promoted organoid invasiveness through STAT3 activation and HERC1 upregulation. Mechanistic validation revealed that HERC1 modulation altered p-STAT3, p-ERK, CD44, and Slug levels, and STAT3 inhibition reduced HERC1 expression, defining a p-STAT3\u2013HERC1\u2013p-ERK axis. IL-6 neutralization or HERC1 inhibition sensitized organoids to 5-fluorouracil and cisplatin, and combined HERC1 knockdown with 5-FU markedly reduced tumor growth and increased apoptosis. Tissue arrays confirmed elevated HERC1 and pathway markers in advanced HNSCC. These findings define an p-STAT3\u2013HERC1\u2013p-ERK signaling axis that promotes cancer stemness and chemoresistance through CD44\n                    <jats:sup>+<\/jats:sup>\n                    tumor\u2013stromal crosstalk. Targeting HERC1 may offer a promising strategy to eliminate cancer stem-like cells in HNSCC.\n                  <\/jats:p>","DOI":"10.1038\/s41388-026-03725-9","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:12:05Z","timestamp":1775895125000},"page":"1840-1855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HERC1 oncogene enhances stemness and tumorigenic potential in CD44+-derived organoids of head and neck squamous cell carcinoma through IL-6\/STAT3 signaling"],"prefix":"10.1038","volume":"45","author":[{"given":"Eunjin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Lin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamin","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5599-4327","authenticated-orcid":false,"given":"Haeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Lyn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Pa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suji","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Yoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5577-9624","authenticated-orcid":false,"given":"Jangok","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5940-3430","authenticated-orcid":false,"given":"Chang-Whan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"3725_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3725_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91:386\u201396.","journal-title":"Mayo Clin Proc"},{"key":"3725_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104:973\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3725_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.20517\/cdr.2022.107","volume":"6","author":"JM Siqueira","year":"2023","unstructured":"Siqueira JM, Heguedusch D, Rodini CO, Nunes FD, Rodrigues M. Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma. Cancer Drug Resist. 2023;6:116\u201337.","journal-title":"Cancer Drug Resist"},{"key":"3725_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.957310","volume":"3","author":"FCA Xavier","year":"2022","unstructured":"Xavier FCA, Silva JC, Rodini CO, Rodrigues M. Mechanisms of immune evasion by head and neck cancer stem cells. Front Oral Health. 2022;3:957310.","journal-title":"Front Oral Health"},{"key":"3725_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110808","volume":"110","author":"SJ Park","year":"2023","unstructured":"Park SJ, Min HJ, Yoon C, Kim SH, Kim JH, Lee SY. Integrin beta1 regulates the perineural invasion and radioresistance of oral squamous carcinoma cells by modulating cancer cell stemness. Cell Signal. 2023;110:110808.","journal-title":"Cell Signal"},{"key":"3725_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbrc.2009.05.048","volume":"385","author":"YC Chen","year":"2009","unstructured":"Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 2009;385:307\u201313.","journal-title":"Biochem Biophys Res Commun"},{"key":"3725_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.7150\/jca.17444","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Wu Y, Gao W, Li F, Bo Y, Zhu M, et al. Identification and characterization of CD133(+)CD44(+) cancer stem cells from human laryngeal squamous cell carcinoma cell lines. J Cancer. 2017;8:497\u2013506.","journal-title":"J Cancer"},{"key":"3725_CR9","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","volume":"69","author":"EH Huang","year":"2009","unstructured":"Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69:3382\u20139.","journal-title":"Cancer Res"},{"key":"3725_CR10","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s12015-023-10593-3","volume":"19","author":"Q Gao","year":"2023","unstructured":"Gao Q, Zhan Y, Sun L, Zhu W. Cancer stem cells and the tumor microenvironment in tumor drug resistance. Stem Cell Rev Rep. 2023;19:2141\u201354.","journal-title":"Stem Cell Rev Rep"},{"key":"3725_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00627-5","volume":"19","author":"Y Li","year":"2021","unstructured":"Li Y, Wang Z, Ajani JA, Song S. Drug resistance and cancer stem cells. Cell Commun. Signal. 2021;19:19.","journal-title":"Cell Commun. Signal"},{"key":"3725_CR12","doi-asserted-by":"publisher","first-page":"e87129","DOI":"10.1371\/journal.pone.0087129","volume":"9","author":"CH Yu","year":"2014","unstructured":"Yu CH, Yu CC. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells. PLoS ONE. 2014;9:e87129.","journal-title":"PLoS ONE"},{"key":"3725_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-3173","volume":"21","author":"HY Jung","year":"2015","unstructured":"Jung HY, Fattet L, Yang J. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Clin Cancer Res. 2015;21:962\u20138.","journal-title":"Clin Cancer Res"},{"key":"3725_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore SG, Doheny DL, Wong GL, Lo HW. IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: biology and treatment. Front Oncol. 2022;12:866014.","journal-title":"Front Oncol"},{"key":"3725_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"3725_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"3725_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/CCO.0000000000000730","volume":"33","author":"A Saint","year":"2021","unstructured":"Saint A, Van Obberghen-Schilling E. The role of the tumor matrix environment in progression of head and neck cancer. Curr Opin Oncol. 2021;33:168\u201374.","journal-title":"Curr Opin Oncol"},{"key":"3725_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41199-020-00051-9","volume":"5","author":"I Micaily","year":"2020","unstructured":"Micaily I, Johnson J, Argiris A. An update on angiogenesis targeting in head and neck squamous cell carcinoma. Cancers Head Neck. 2020;5:5.","journal-title":"Cancers Head Neck"},{"key":"3725_CR19","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3390\/cancers13123027","volume":"13","author":"R Gonzalez-Gonzalez","year":"2021","unstructured":"Gonzalez-Gonzalez R, Ortiz-Sarabia G, Molina-Frechero N, Salas-Pacheco JM, Salas-Pacheco SM, Lavalle-Carrasco J. Epithelial-mesenchymal transition associated with head and neck squamous cell carcinomas: a review. Cancers. 2021;13:3027.","journal-title":"Cancers"},{"key":"3725_CR20","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/bjc.2014.438","volume":"111","author":"Y Hassona","year":"2014","unstructured":"Hassona Y, Cirillo N, Heesom K, Parkinson EK, Prime SS. Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion. Br J Cancer. 2014;111:1230\u20137.","journal-title":"Br J Cancer"},{"key":"3725_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640392","volume":"11","author":"Y Kanno","year":"2021","unstructured":"Kanno Y, Chen CY, Lee HL, Chiou JF, Chen YJ. Molecular mechanisms of chemotherapy resistance in head and neck cancers. Front Oncol. 2021;11:640392.","journal-title":"Front Oncol"},{"key":"3725_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.coms.2018.09.003","volume":"31","author":"SK Sindhu","year":"2019","unstructured":"Sindhu SK, Bauman JE. Current concepts in chemotherapy for head and neck cancer. Oral Maxillofac Surg Clin North Am. 2019;31:145\u201354.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"3725_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03130-2","volume":"23","author":"Q Liu","year":"2023","unstructured":"Liu Q, Guo Z, Li G, Zhang Y, Liu X, Li B, et al. Cancer stem cells and their niche in cancer progression and therapy. Cancer Cell Int. 2023;23:305.","journal-title":"Cancer Cell Int"},{"key":"3725_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.15537\/smj.2021.42.3.20210660","volume":"42","author":"AF Alfouzan","year":"2021","unstructured":"Alfouzan AF. Radiation therapy in head and neck cancer. Saudi Med J. 2021;42:247\u201354.","journal-title":"Saudi Med J"},{"key":"3725_CR25","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1038\/s41388-020-1250-3","volume":"39","author":"MND Hutchinson","year":"2020","unstructured":"Hutchinson MND, Mierzwa M, D\u2019Silva NJ. Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer. Oncogene. 2020;39:3638\u201349.","journal-title":"Oncogene"},{"key":"3725_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcdb.2021.11.017","volume":"132","author":"EM Perez-Villegas","year":"2022","unstructured":"Perez-Villegas EM, Ruiz R, Bachiller S, Ventura F, Armengol JA, Rosa JL. The HERC proteins and the nervous system. Semin Cell Dev Biol. 2022;132:5\u201315.","journal-title":"Semin Cell Dev Biol"},{"key":"3725_CR27","doi-asserted-by":"publisher","first-page":"31531","DOI":"10.18632\/oncotarget.25847","volume":"9","author":"T Schneider","year":"2018","unstructured":"Schneider T, Martinez-Martinez A, Cubillos-Rojas M, Bartrons R, Ventura F, Rosa JL. The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation. Oncotarget. 2018;9:31531\u201348.","journal-title":"Oncotarget"},{"key":"3725_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57756-7","volume":"10","author":"L Pedrazza","year":"2020","unstructured":"Pedrazza L, Schneider T, Bartrons R, Ventura F, Rosa JL. The ubiquitin ligase HERC1 regulates cell migration via RAF-dependent regulation of MKK3\/p38 signaling. Sci Rep. 2020;10:824.","journal-title":"Sci Rep"},{"key":"3725_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fphys.2019.01144","volume":"10","author":"S Fouad","year":"2019","unstructured":"Fouad S, Wells OS, Hill MA, D\u2019Angiolella V. Cullin ring ubiquitin ligases (CRLs) in cancer: responses to ionizing radiation (IR) treatment. Front Physiol. 2019;10:1144.","journal-title":"Front Physiol"},{"key":"3725_CR30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.tibs.2019.08.004","volume":"44","author":"F Bernassola","year":"2019","unstructured":"Bernassola F, Chillemi G, Melino G. HECT-type E3 ubiquitin ligases in cancer. Trends Biochem Sci. 2019;44:1057\u201375.","journal-title":"Trends Biochem Sci"},{"key":"3725_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10020-023-00628-3","volume":"29","author":"R Zhang","year":"2023","unstructured":"Zhang R, Shi S. The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives. Mol Med. 2023;29:34.","journal-title":"Mol Med"},{"key":"3725_CR32","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s11605-022-05568-7","volume":"27","author":"C Yoon","year":"2023","unstructured":"Yoon C, Lu J, Kim BJ, Cho SJ, Kim JH, Moy RH, et al. Patient-derived organoids from locally advanced gastric adenocarcinomas can predict resistance to neoadjuvant chemotherapy. J Gastrointest Surg. 2023;27:666\u201376.","journal-title":"J Gastrointest Surg"},{"key":"3725_CR33","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","volume":"25","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Wu C, O\u2019Rourke KP, Szeglin BC, Zheng Y, Sauve CG, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med. 2019;25:1607\u201314.","journal-title":"Nat Med"},{"key":"3725_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"3725_CR35","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/archoto.2010.219","volume":"136","author":"SJ Davis","year":"2010","unstructured":"Davis SJ, Divi V, Owen JH, Bradford CR, Carey TE, Papagerakis S, et al. Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136:1260\u20136.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"3725_CR36","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023;55:1322\u201332.","journal-title":"Exp Mol Med"},{"key":"3725_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.17998\/jlc.2023.04.30","volume":"23","author":"K Mun","year":"2023","unstructured":"Mun K, Han J, Roh P, Park J, Kim G, Hur W, et al. Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma. J Liver Cancer. 2023;23:341\u20139.","journal-title":"J Liver Cancer"},{"key":"3725_CR38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41416-025-03074-6","volume":"133","author":"H Liang","year":"2025","unstructured":"Liang H, Benard O, Kumar V, Griffen A, Ren Z, Sivalingam K, et al. Wnt\/ERK\/CDK4\/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation. Br J Cancer. 2025;133:986\u20131002.","journal-title":"Br J Cancer"},{"key":"3725_CR39","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.3390\/cancers13164057","volume":"13","author":"YY Wang","year":"2021","unstructured":"Wang YY, Vadhan A, Chen PH, Lee YL, Chao CY, Cheng KH. CD44 promotes lung cancer cell metastasis through ERK-ZEB1 signaling. Cancers. 2021;13:4057.","journal-title":"Cancers"},{"key":"3725_CR40","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cancers13061309","volume":"13","author":"FA Rossi","year":"2021","unstructured":"Rossi FA, Calvo Roitberg EH, Enrique Steinberg JH, Joshi MU, Espinosa JM, Rossi M. HERC1 regulates breast cancer cells migration and invasion. Cancers. 2021;13:1309.","journal-title":"Cancers"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03725-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:02:38Z","timestamp":1777932158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03725-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,5,26]]}},"alternative-id":["3725"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03725-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve human participants or patient-derived materials; therefore, Institutional Review Board (IRB) approval and informed consent were not required. All animal experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC), and human cell lines were handled following institutional biosafety and ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}